Skip to content
Screener

Utah Medical Products UTMD Q1 2025 earnings

Reported April 29, 2025 · Before market open

Revenue$9.7M
EPS$0.92

Next report

Oct 22, 2026 (In 1 week)

Financials

Q1 2025

Income statement

See full
Revenue$9.7M-14.4%
Gross profit$5.5M-18.1%
Operating income$3.2M-18.8%
Net income$3.0M-23.1%
EPS (diluted)$0.92-15.6%

Balance sheet

See full
Cash & equivalents$83.3M-11.2%
Total equity$117.0M-8.4%
Total assets$122.5M-9.5%

Cash flow

See full
Operating cash flow$4.5M-15.4%
CapEx$184.0K+736%
Free cash flow$4.3M-18.5%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$183.91M-28.5%
P/E14.2×-1.5×
P/S4.7×-0.6×

Profitability

See full
Gross margin58.4%-0.7pp
Operating margin32.8%-0.3pp
Net margin33%-0.4pp
FCF margin34.7%-6.1pp

Returns & leverage

See full
Return on equity10.6%-2.7pp
Current ratio22.3×+2.7×

Segments

By product

See full
Gynecology/Electrosurgery/Urology$4.9M-10.3%
Neonatal$2.0M+20.7%
Blood Pressure Monitoring and Accessories$1.8M-43.7%
Obstetrics$1.0M0.0%

By geography

See full
Global$9.6M-5.8%
Ous$3.9M-9.7%

FAQ

When did Utah Medical Products report Q1 2025 earnings?
Utah Medical Products (UTMD) reported Q1 2025 earnings on April 29, 2025 before market open.
What were Utah Medical Products's Q1 2025 revenue and EPS?
Utah Medical Products reported revenue of $9.7M and eps of $0.92 for Q1 2025.
How did Utah Medical Products's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 14.4% from $11.3M a year earlier and eps declined 15.6% from $1.09.
Where can I find Utah Medical Products's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001096906-25-000625) and the 10-Q periodic report (0001096906-25-000816) directly on SEC EDGAR. The filing index links above go to sec.gov.